PAVmed (PAVM) Preferred Shares (2017 - 2025)

PAVmed's Preferred Shares history runs 9 years deep, the most recent figure standing at $3.7 million for Q4 2025.

• On a quarterly basis, Preferred Shares rose 10.52% year-over-year to $3.7 million in Q4 2025; TTM through Dec 2025 was $3.7 million, a 10.52% increase from a year earlier, with the FY2025 full-year figure at $3.7 million, up 10.52% from the prior year.
• Preferred Shares fell to $3.7 million in Q4 2025 per PAVM's latest filing, from $20.5 million in the prior quarter.
• Across five years, Preferred Shares topped out at $20.5 million in Q3 2025 and bottomed at $2.4 million in Q3 2021.
• The 5-year median for Preferred Shares is $2.8 million (2023), against an average of $3.8 million.
• Across the five-year window, Preferred Shares dropped 4.65% in 2021 and gained 11.56% in 2022, its largest moves.
• Year by year, Preferred Shares stood at $2.4 million in 2021, then grew by 11.41% to $2.7 million in 2022, then advanced by 11.06% to $3.0 million in 2023, then rose by 10.79% to $3.3 million in 2024, then grew by 10.52% to $3.7 million in 2025.
• Per Business Quant, the three latest PAVM Preferred Shares figures stand at $3.7 million (Q4 2025), $20.5 million (Q3 2025), and $3.5 million (Q2 2025).